- Home
- CLPT vs CMPX Comparison
CLPT vs CMPX Comparison
Compare CLPT & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- CMPX
- Stock Information
- Founded
- CLPT 1998
- CMPX 2014
- Country
- CLPT United States
- CMPX United States
- Employees
- CLPT N/A
- CMPX N/A
- Industry
- CLPT Medical/Dental Instruments
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- CMPX Health Care
- Exchange
- CLPT Nasdaq
- CMPX Nasdaq
- Market Cap
- CLPT 317.4M
- CMPX 291.8M
- IPO Year
- CLPT N/A
- CMPX N/A
- Fundamental
- Price
- CLPT $10.70
- CMPX $3.02
- Analyst Decision
- CLPT Strong Buy
- CMPX Strong Buy
- Analyst Count
- CLPT 3
- CMPX 8
- Target Price
- CLPT $27.67
- CMPX $13.50
- AVG Volume (30 Days)
- CLPT 399.1K
- CMPX 1.4M
- Earning Date
- CLPT 08-12-2025
- CMPX 08-11-2025
- Dividend Yield
- CLPT N/A
- CMPX N/A
- EPS Growth
- CLPT N/A
- CMPX N/A
- EPS
- CLPT N/A
- CMPX N/A
- Revenue
- CLPT $33,593,000.00
- CMPX N/A
- Revenue This Year
- CLPT $23.97
- CMPX N/A
- Revenue Next Year
- CLPT $27.52
- CMPX N/A
- P/E Ratio
- CLPT N/A
- CMPX N/A
- Revenue Growth
- CLPT 19.68
- CMPX N/A
- 52 Week Low
- CLPT $9.76
- CMPX $1.18
- 52 Week High
- CLPT $19.22
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- CLPT 46.60
- CMPX 53.56
- Support Level
- CLPT $10.06
- CMPX $2.66
- Resistance Level
- CLPT $11.95
- CMPX $3.47
- Average True Range (ATR)
- CLPT 0.60
- CMPX 0.25
- MACD
- CLPT -0.02
- CMPX -0.03
- Stochastic Oscillator
- CLPT 36.22
- CMPX 44.44
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.